Artiva Biotherapeutics, Inc. · NASDAQ:ARTV

Aslan Fred received 110,000 Artiva Biotherapeutics, Inc. shares as an award (Form 4)

Traded Sep 15, 2026 · Filed Sep 15, 2026

On Sep 15, 2026, Aslan Fred (Director, Chief Executive Officer) received 110,000 Artiva Biotherapeutics, Inc. shares as an award, leaving 1,604,765 shares. Filed Sep 15, 2026 (Form 4).

Awarded
110,000 shares
Holding after
1,604,765 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 15, 2026Common StockAward110,0001,604,765Direct

Source

View original at SEC

Related